posted on 2021-07-30, 13:57authored byJaneth Dula, Alexandre Mulhanga, Armindo Nhanombe, Laurentino Cumbi, António Júnior, Joe Gwatsvaira, Joseph Nelson Siewe Fodjo, Edlaine Faria de Moura Villela, Sérgio Chicumbe, Robert Colebunders
A high worldwide SARS-CoV-2 vaccine coverage must be attained to stop the COVID-19
pandemic. In this study, we assessed the level of willingness of Mozambicans to be vaccinated against
COVID-19. Data were collected between 11 and 20 March 2021, through a self-administered online
survey. Of the 1878 respondents, 30.1% were healthcare workers, 58.3% were aged between 18 and
35 years, 60% were male, and 38.5% were single. Up to 43% had been tested for COVID-19 and 29%
had tested positive. Overall vaccine acceptability was 71.4% (86.6% among healthcare workers, 64.8%
among other respondents; p < 0.001). Reasons for vaccine hesitancy included: fear of vaccine side
effects (29.6%) and the belief that the vaccine is not effective (52%). The acceptability of the SARS CoV-2 vaccine increased with increasing vaccine efficacy. Using logistic regression, determinants for
acceptability of the vaccine were: older age, a past COVID-19 test, a concern of becoming (re)infected
by COVID-19, having a chronic disease, and considering vaccination important for personal and
community health. In conclusion, vaccine acceptability in Mozambique was relatively high among
healthcare workers but significantly lower in the rest of the population. This suggests that there is a
need to educate the general population about SARS-CoV-2 vaccination and its importance.
History
Publication
Vaccines;9, 828
Publisher
MDPI
Note
peer-reviewed
Other Funding information
VLIRUOS (Flemish Interuniversity Council for University Development Cooperation)